- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Moderate Epithelial Dysplasia
Total 23755 results
-
Edimer PharmaceuticalsActive, not recruitingX-linked Hypohidrotic Ectodermal DysplasiaUnited States, United Kingdom, France, Germany, Italy
-
Edimer PharmaceuticalsCompletedX-Linked Hypohidrotic Ectodermal DysplasiaUnited States, United Kingdom, France, Germany, Italy
-
CSA Medical, Inc.TerminatedBarrett's Esophagus | Low Grade Dysplasia | High Grade DysplasiaUnited States
-
National Cancer Institute (NCI)Active, not recruitingColorectal Adenoma | Colorectal Adenoma With Severe Dysplasia | Colorectal Tubulovillous AdenomaUnited States, Puerto Rico
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI)CompletedEsophagitis | Weight Loss | Gastroesophageal Reflux Disease | Dysphagia | Esophageal Adenocarcinoma | Esophageal Squamous Cell Carcinoma | Dysplasia | High Grade Dysplasia in Barrett EsophagusUnited States
-
Boston Medical CenterUniversity of Alabama at BirminghamWithdrawnLow-grade Oral DysplasiaUnited States
-
Edimer PharmaceuticalsCompletedX-Linked Hypohidrotic Ectodermal DysplasiaUnited States, United Kingdom, France, Germany, Italy
-
Edimer PharmaceuticalsCompletedHypohidrotic Ectodermal Dysplasia | X-Linked Hypohidrotic Ectodermal DysplasiaUnited States
-
Edimer PharmaceuticalsNational Foundation of Ectodermal DysplasiaCompletedHypohidrotic Ectodermal Dysplasia | X-Linked Hypohidrotic Ectodermal DysplasiaUnited States
-
JHM BioPharma (Tonghua) Co. , Ltd.Recruiting
-
AbbVieCompletedModerate to Severe Glabellar LinesJapan
-
Chongqing Claruvis Pharmaceutical Co., Ltd.CompletedModerate to Severe Glabellar LinesChina
-
Károli Gáspár University of the Reformed Church...University of TorontoCompletedMild to Moderate Psychopathological SymptomsHungary
-
Croma-Pharma GmbHCompleted
-
Károli Gáspár University of the Reformed Church...University of TorontoCompletedMild to Moderate Psychopathological SymptomsHungary
-
AllerganCompletedModerate to Severe Nasolabial FoldsUnited States
-
Institute for Clinical Effectiveness and Health...Inter-American Development BankUnknownModerate and High Cardiovascular RiskArgentina
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States, Canada
-
Chang Gung Memorial HospitalCompletedCraniofacial Fibrous DysplasiaTaiwan
-
AMIpharm Co., Ltd.CompletedModerate or Severe Submental FullnessKorea, Republic of
-
IpsenCompletedModerate to Severe Glabellar LinesFrance, Germany
-
Kythera BiopharmaceuticalsBayerCompletedModerate or Severe Submental FullnessGermany, France, Belgium, Spain, United Kingdom
-
Kythera BiopharmaceuticalsCompletedPhase 1-2 Study of Deoxycholic Acid Injection (ATX-101) for the Reduction of Submental Fat (ATX-101)Moderate or Severe Submental FullnessUnited Kingdom, Canada, Australia
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States, Canada
-
Daewoong Pharmaceutical Co. LTD.CompletedModerate to Severe Glabellar LineKorea, Republic of
-
Adenocyte, LLCCompleted
-
Tenwek HospitalMayo Clinic; Kenyatta National Hospital; AORTICCompletedEsophageal DysplasiaKenya
-
Hospital Sao JoaoCompletedGastric Dysplasia | NeoplasiaPortugal
-
Edwards LifesciencesActive, not recruiting
-
NestléCompletedMild to Moderate Levels of StressSwitzerland
-
Merz North America, Inc.CompletedModerate to Severe Midface Volume DeficitCanada
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Canada
-
University of VirginiaUnknownEducational Problems | Cervix, DysplasiaUnited States
-
Edimer PharmaceuticalsCompletedX Linked Hypohidrotic Ectodermal DysplasiaUnited States
-
National Institute of Dental and Craniofacial Research...CompletedPolyostotic Fibrous DysplasiaUnited States
-
Merz Aesthetics GmbHMerz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Germany
-
Croma-Pharma GmbHActive, not recruitingModerate to Severe Midface Volume DeficitUnited States
-
University of LahoreRiphah International UniversityCompletedOlder Adults With Moderate Balance RiskPakistan
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States
-
Assiut UniversityRecruitingDevelopmental Hip DysplasiaEgypt
-
Istituto Ortopedico RizzoliCompleted
-
Tishreen UniversityCompletedMild to Moderate Anterior Mandibular Segment CrowdindSyrian Arab Republic
-
AllerganCompletedPatients With Moderate to Severe Perioral LinesUnited States
-
Edimer PharmaceuticalsCompletedEctodermal DysplasiaUnited States
-
Lawson Health Research InstituteUniversity of Western Ontario, CanadaTerminatedMucinous Cystic Tumor With Moderate Dysplasia | Mucinous Cystadenoma of Pancreas | Mucinous Cystadenocarcinoma of Pancreas | Benign Neoplasm of PancreasCanada
-
Lucid Diagnostics, Inc.RecruitingBarrett Esophagus | Esophageal Adenocarcinoma | Barrett's Esophagus Without Dysplasia | Barretts Esophagus With DysplasiaUnited States
-
Hospices Civils de LyonCompletedFibrous Dysplasia of Bone | McCune Albright SyndromeFrance
-
Edimer PharmaceuticalsCompletedHypohidrotic Ectodermal DysplasiaUnited States